Monday, February 8, 2016

Pharma industry blogger reports layoffs in Merck R&D

The In the Pipeline blog doesn't have numbers, but has gotten reports of cuts in people at West Point and in Montreal.

Pharma industry blogger reports layoffs in Merck R&D


With Merck & Co. Inc. buying Schering-Plough Corp., everyone expects there will be job cuts once the deal is done.

But layoffs going on right now?

The prominent pharmaceutical blog In the Pipeline has posting today about layoffs at Merck R&D operations in West Point (Montgomery County) and in Montreal.

You can read the post here.

Some commenters to the posting say that these are cuts that have been the works before the Schering-Plough deal was announced. That could mean any layoffs now are part of Merck CEO Richard Clark's "Plan to Win" restructuring, which is into its fourth year.

UPDATE: Ian McConnell from Merck's media relations office e-mailed me Friday afternoon with the following statement:

The restructuring is based on a careful analysis of the strengths and weaknesses of our basic research organization aimed at better alignment of our staff and resources. These changes are the latest step in our, previously announced, strategy focused on improving the productivity of research and development efforts.

In October, Merck did announced that it planned to cut 7,200 jobs worldwide. Those cuts were be completed by 2011 and represented about 12 percent of the Whitehouse Station, N.J. company's worldwide workforce.

Inquirer Columnist
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

Mike Armstrong Inquirer Columnist
Also on
letter icon Newsletter